急性心力衰竭中既往肌钙蛋白升高的意义:并非如先前认为的那样令人安心
该前瞻性多中心研究纳入5个中心341例急性心衰患者,复合主要终点为90天内死亡/心肺复苏、机械心脏支持、插管、新发/急诊透析和/或AMI/PCI/CABG。急诊就诊时cTn升高经既往cTn等协变量调整后与主要终点相关(aOR 2.39,95%CI 1.30-4.38)。既往cTn升高仅在缺血性心脏病史未知时与主要终点风险升高相关(aOR 5.27,95%CI 1.24-21.40),在已知阳性或阴性病史者中未改变结局 odds。急诊cTn升高且既往cTn也升高者出院比例更高(78% vs 32%,p=0.025)。
要点
- 急诊就诊时cTn升高与90天复合主要终点独立相关(aOR 2.39,95%CI 1.30-4.38)。
- 缺血性心脏病史未知时,既往cTn升高与主要终点风险升高相关(aOR 5.27,95%CI 1.24-21.40)。
- 缺血性心脏病史已知阳性时,既往cTn升高不改变结局 odds(aOR 0.74,95%CI 0.33-1.70)。
- 缺血性心脏病史已知阴性时,既往cTn升高不改变结局 odds(aOR 0.79,95%CI 0.26-2.40)。
- 急诊cTn升高且既往cTn也升高者出院比例78% vs 32%(p=0.025),提示该人群被更轻易出院。
适用人群与场景
- 急性心力衰竭(AHF)患者,来自5个中心的前瞻性队列,共341例。
研究设计与关键结果
- 研究设计:前瞻性多中心研究,5个中心,341例AHF患者。
- 主要复合终点:90天内死亡/心肺复苏、机械心脏支持、插管、新发/急诊透析和/或AMI/PCI/CABG;80例(23%)发生主要终点。
- 急诊cTn升高163例(49%);AMI 29例(9%)。
- 急诊cTn升高经既往cTn及其他协变量调整后与主要终点相关(aOR 2.39,95%CI 1.30-4.38),并与30天AMI/PCI/CABG及院内AMI相关。
- 缺血性心脏病史未知时,既往cTn升高与主要终点风险升高相关(aOR 5.27,95%CI 1.24-21.40)。
- 缺血性心脏病史已知阳性时,既往cTn升高不改变主要终点 odds(aOR 0.74,95%CI 0.33-1.70);已知阴性时亦不改变(aOR 0.79,95%CI 0.26-2.40)。
- 急诊cTn升高患者中,既往cTn也升高者出院比例更高(78% vs 32%,p=0.025)。
证据类型、等级与局限
- 证据类型:前瞻性多中心研究(5个中心,341例)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,AHF患者既往cTn升高对未做过缺血性心脏病评估者是预后更差的预兆,应促使评估潜在缺血,而不是作为出院的安心依据。
- 作者认为,在已知缺血性心脏病史的患者中,既往cTn升高既不令人安心也无害,未能为当前cTn升高增加额外预后价值。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Historical cardiac troponin (cTn) elevation is commonly interpreted as lessening the significance of current cTn elevations at presentation for acute heart failure (AHF). Evidence for this practice is lacking. Our objective was to determine the incremental prognostic significance of historical cTn elevation compared to cTn elevation and ischemic heart disease (IHD) history at presentation for AHF.
METHODS: A total of 341 AHF patients were prospectively enrolled at five sites. The composite primary outcome was death/cardiopulmonary resuscitation, mechanical cardiac support, intubation, new/emergent dialysis, and/or acute myocardial infarction (AMI)/percutaneous coronary intervention (PCI)/coronary artery bypass grafting (CABG) at 90 days. Secondary outcomes were 30-day AMI/PCI/CABG and in-hospital AMI. Logistic regression compared outcomes versus initial emergency department (ED) cTn, the most recent electronic medical record cTn, estimated glomerular filtration rate, age, left ventricular ejection fraction, and IHD history (positive, negative by prior coronary workup, or unknown/no prior workup).
RESULTS: Elevated cTn occurred in 163 (49%) patients, 80 (23%) experienced the primary outcome, and 29 had AMI (9%). cTn elevation at ED presentation, adjusted for historical cTn and other covariates, was associated with the primary outcome (adjusted odds ratio [aOR] 2.39, 95% confidence interval [CI] 1.30-4.38), 30-day AMI/PCI/CABG, and in-hospital AMI. Historical cTn elevation was associated with greater odds of the primary outcome when IHD history was unknown at ED presentation (aOR 5.27, 95% CI 1.24-21.40) and did not alter odds of the outcome with known positive (aOR 0.74, 95% CI 0.33-1.70) or negative IHD history (aOR 0.79, 95% CI 0.26-2.40). Nevertheless, patients with elevated ED cTn were more likely to be discharged if historical cTn was also elevated (78% vs. 32%, p = 0.025).
CONCLUSIONS: Historical cTn elevation in AHF patients is a harbinger of worse outcomes for patients who have not had a prior IHD workup and should prompt evaluation for underlying ischemia rather than reassurance for discharge. With known IHD history, historical cTn elevation was neither reassuring nor detrimental, failing to add incremental prognostic value to current cTn elevation alone.
参考来源
- Harrison NE, Ehrman R, Pang P, et al. The significance of historical troponin elevation in acute heart failure: Not as reassuring as previously assumed. Acad Emerg Med. 2023. PMID: 37641846. doi:10.1111/acem.14798
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。